The Possibility Of Integrating Motile Sperm Organelle Morphology Examination (Msome) With Intracytoplasmic Morphologically-Selected Sperm Injection (Imsi) When Treating Couples With Unexplained Infertility

PurposeTo examine the efficacy of motile sperm organelle morphology examination (MSOME) and intracytoplasmic morphologically-selected sperm injection (IMSI) for unexplained infertility.MethodsThis historical study, included 271 couples with primary, unexplained infertility/male subfertility, treated at an outpatient, IVF clinic, 2015-2018. These couples underwent MSOME after >= 3 failed intrauterine insemination (IUI) cycles and >= 1 failed IVF-ICSI cycle. They proceeded to intracytoplasmic morphologically-selected sperm injection (IMSI) within 6 months of MSOME. IMSI is conducted on the day of oocyte pick-up with a fresh semen sample. Pregnancy and delivery rates were analyzed.ResultsThe cohort was divided based on percentage of normal cells at MSOME: Group A included 55 with no normal cells, Group B, 184 with 0.5% <= normal cells <= 1.5% and Group C, 32 with >= 2% normal cells. Normal spermatozoa were found in 49 (89%) of Group A after extensive search. Group A had higher pregnancy rate (62.7%) compared to B (47.2%, P = 0.05) and C (28.1%, P = 0.002). Group B had higher pregnancy rate than C (p = 0.045). Delivery rate was higher in Group A (52.1%) compared to B (34.1%, p = 0.023) and C (21.9%, p = 0.007). Pregnancy and delivery rates were higher in A compared to B+C (p = 0.018, p = 0.01, respectively).ConclusionsMSOME may be useful for evaluating unexplained infertility. IMSI can be recommended for men with < 2% normal spermatozoa at MSOME.